| Name | Title | Contact Details |
|---|
LuxCath is the leader in using fluorescence and optics to directly view lesions during cardiac ablation procedures. The company`s breakthrough technology offers the potential for dramatic evolution in the way ablation procedures are performed by assessing tissue contact and enabling direct lesion progression monitoring. LuxCath`s patented solution aims to ensure the quality of catheter lesions at the moment they are made. LuxCath enables constant optical tissue contact assessment and provides valuable lesion formation and progression information during each ablation.
Biosense Webster is offering you exposure to the best-in-class AF* practices through our Centers of Excellence program. Our Centers of Excellence provide you with the opportunity to fine tune your approach to PAF ablation by observing cases at
Subtle, Inc., is a medical imaging software company. Our goal is to improve the quality, value, and accessibility of medical imaging by significantly reducing cost, imaging time, and radiation dose.
Bios International Corp is a Butler, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
SciCan Ltd is a North York, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.